Safety of three different product doses in autologous chondrocyte implantation: results of a prospective, randomised, controlled trial

BACKGROUND: This study was conducted to assess the efficacy and safety of the three dose levels of the three-dimensional autologous chondrocyte implantation product chondrosphere® in the treatment of cartilage defects (4–10 cm(2)) of knee joints. We hereby report the safety results for a 36-month po...

Descripción completa

Detalles Bibliográficos
Autores principales: Becher, Christoph, Laute, Volker, Fickert, Stefan, Zinser, Wolfgang, Niemeyer, Philipp, John, Thilo, Diehl, Peter, Kolombe, Thomas, Siebold, Rainer, Fay, Jakob
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5429514/
https://www.ncbi.nlm.nih.gov/pubmed/28499391
http://dx.doi.org/10.1186/s13018-017-0570-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5429514/
https://www.ncbi.nlm.nih.gov/pubmed/28499391
http://dx.doi.org/10.1186/s13018-017-0570-7

Ejemplares similares